Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
United States
Mayo Clinic, Rochester, Minnesota Washington University, St Louis, Missouri Cleveland Clinic Foundation, Cleveland, Ohio Huntsman Cancer Institute, Salt Lake City, Utah